RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas
Clinical trial NCT07506668 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07506668
- Sponsor
- Affiliated Hospital of Nantong University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-23
- Primary completion
- 2028-03-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.